IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
UP-0490583
(2006-07-22)
|
등록번호 |
US-7858363
(2011-02-24)
|
발명자
/ 주소 |
|
출원인 / 주소 |
- Zymo Research Corporation
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
1 인용 특허 :
4 |
초록
Apparatus, reagents, and methods for isolating plasmid DNA from bacteria by alkaline lysis using a solid or immobilized P2 and/or P3 reagent in combination with a DNA-binding matrix.
대표청구항
▼
The invention claimed is: 1. A lysate filtration device for filtering a bacterial alkaline lysate, the device comprising a mixing chamber, having a top and bottom opening, a P3 reagent provided in the mixing chamber as a dry formulation, a filtering media positioned in the mixing chamber, the filte
The invention claimed is: 1. A lysate filtration device for filtering a bacterial alkaline lysate, the device comprising a mixing chamber, having a top and bottom opening, a P3 reagent provided in the mixing chamber as a dry formulation, a filtering media positioned in the mixing chamber, the filtering media being separate from the P3 reagent and in fluid contact with the mixing chamber, the mixing chamber being configured to receive a bacterial alkaline lysate through the top opening, wherein contact between the P3 reagent and the bacterial alkaline lysate can occur, whereby contact between the P3 reagent and the bacterial alkaline lysate will result in a neutralized lysate, the neutralized lysate further comprising a flocculent bacterial debris and a remaining bacterial lysate, and wherein the filtering media is for filtering the flocculent bacterial debris, from the remaining bacterial lysate. 2. An apparatus comprising the lysate filtration device of claim 1 in fluid contact with a DNA capture device, the DNA capture device having a DNA-binding matrix provided in the DNA capture device, wherein filtered lysate from the lysate filtration device can contact the DNA-binding matrix in the DNA capture device, and wherein plasmid DNA in the lysate filtrate can bind to the DNA binding matrix. 3. The apparatus of claim 2, further comprising a sealing cap, and wherein the lysate filtration device and sealing cap together form the mixing chamber. 4. The apparatus of claim 3, further comprising the P3 reagent disposed in the sealing cap. 5. The apparatus of claim 3 further comprising the P3 reagent disposed under or behind a water-soluble protective barrier or film; wherein the water-soluble protective barrier is positioned to dissolve upon contact with a cell suspension. 6. The apparatus of claim 1, wherein the apparatus is a spin-column apparatus. 7. The apparatus of claim 6, wherein the apparatus is in multi-well format. 8. A kit comprising the apparatus of claim 6. 9. A kit comprising the apparatus of claim 7. 10. The apparatus of claim 3 wherein the lysate filtration device and the DNA capture device are linked. 11. The apparatus of claim 10 wherein the linked device forms one mixing chamber. 12. A lysate filtration device for filtering a bacterial alkaline lysate, the device comprising a mixing chamber, having a top and bottom opening, a P2 and a P3 and reagent provided in the mixing chamber, the P2 and P3 reagents being disposed as dry formulations, wherein the P2 media is disposed to contact a cell suspension and dissolve before the P3 reagent, a filtering media positioned in the mixing chamber, the filtering media being separate from the P2 and P3 reagents, wherein the filtering media is in fluid contact with the mixing chamber, the mixing chamber being configured to receive a bacterial cell suspension through the top opening, whereby contact between the bacterial cell suspension and the P2 and P3 reagents can occur, and whereby contact between the bacterial cell suspension, the P2 reagent and the P3 reagent will result in a bacterial alkaline lysate that is rapidly neutralized, the neutralized lysate further comprising a flocculent bacterial debris and a remaining bacterial lysate, and wherein the filtering media is for filtering the flocculent bacterial debris, from the remaining bacterial lysate. 13. The apparatus of claim 2, wherein the dry formulation P3 reagent is selected from the group consisting of tablets, powders, granules, crystals, chalks, films, and polymers. 14. The apparatus of claim 2, wherein the dry formulation P3 further comprises a potassium salt, a chaotropic agent, and a solid acid. 15. The apparatus of claim 14, wherein the solid acid is selected from the group consisting of malic acid, citric acid, malonic acid, maleic acid, succinic acid, tartaric acid, and pyruvic acid. 16. The apparatus of claim 14, wherein the chaotropic agent is selected from the group consisting of guanidinium-HCl, iodide, perchlorate, and trichloroacetate.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.